Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
Summary: Background: Allergen immunotherapy (AIT) is the only causal treatment for respiratory allergy. Long-term real-life effectiveness of AIT remains to be demonstrated beyond the evidence from randomised controlled trials (RCTs). Methods: REACT (Real world effectiveness in allergy immunotherapy...
Enregistré dans:
Auteurs principaux: | Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, Sarah Buchs, Julie Rask Larsen, Lisa Elliott, Mercedes Romano Rodriguez, Nick Freemantle |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2022
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a6b5c685a2174bc59d4c97bcccb513a1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
EFFICIENCY OF PHARMACOTHERAPY IN ALLERGIC RHINITIS, AS EVALUATED BY DECREASED CONCENTRATIONS OF FREE HEMOGLOBIN IN NASAL SECRETIONS
par: A. A. Mokronosova, et autres
Publié: (2014) -
Comparative Study between Intranasal Injection of Botulinum Toxin-A and Combined Intranasal Medical Treatment for Allergic Rhinitis
par: Nabil Sarhan, et autres
Publié: (2020) -
Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
par: Tankersley M, et autres
Publié: (2021) -
Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
par: Anne K. Ellis, et autres
Publié: (2021) -
Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis
par: Eli O. Meltzer, et autres
Publié: (2021)